Gene · 5771
Papers2,250
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,250
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Towards Precision Medicine in Inflammatory Bowel Diseases: Pharmacogenetic Predictors of Ustekinumab Effectiveness and Persistence. | Pharmaceuticals (Basel) | 2026 | 42797473 | PubTator, text mining | PubMed |
| PTPN2 Deletion Enhances CAR-T Effector Function and CNS Trafficking in a Non-Human Primate Model. | Blood Adv | 2026 | 42685352 | PubTator, text mining | PubMed |
| PTPN1 and PTPN2 cooperatively set interferon responsiveness thresholds that govern cancer immune evasion. | Proc Natl Acad Sci U S A | 2026 | 42579487 | PubTator, text mining | PubMed |
| Molecular Mechanisms and Targeted Therapies of PTPN2 in Metabolic Diseases: A Review. | Biomolecules | 2026 | 42509809 | PubTator, text mining | PubMed |
| PTPN2-Associated Immune Dysregulation Presenting With Autoimmune Cytopenias, Lymphoproliferation, and Recurrent Intussusception. | Pediatr Blood Cancer | 2026 | 42488986 | PubTator, text mining | PubMed |
| Uncompetitive Allosteric Inhibition of PTP1B by BP-1-102 Reveals a Potential Dual-Target Strategy toward the PTP1B-STAT3 Oncogenic Axis: Biochemical and Computational Evidence. | ACS Med Chem Lett | 2026 | 42445032 | PubTator, text mining | PubMed |
| Whole genome-based polygenic risk score and structural variation analysis in Korean patients with inflammatory bowel disease. | BMB Rep | 2026 | 42226727 | PubTator, text mining | PubMed |
| Calix[4]Arene α-Ketophosphonic Acids as Photoactivatable Inhibitors of Protein Tyrosine Phosphatases. | Chem Biodivers | 2026 | 42216850 | PubTator, text mining | PubMed |
| Reprogramming the diseased liver: antioxidant-engineered mRNA nanoparticles as microenvironment modulators in MAFLD. | Immunometabolism (Cobham) | 2026 | 42163952 | PubTator, text mining | PubMed |
| Unraveling the layers of epigenetic control in respiratory antiviral defense. | J Virol | 2026 | 42159289 | PubTator, text mining | PubMed |
| A Novel PTPN2 Isoform Differentially Regulates Immune Response. | Eur J Immunol | 2026 | 42153603 | PubTator, text mining | PubMed |
| A thiosemicarbazone-based dinuclear copper(II) complex: potent antiproliferative activity, distinct cell-type-specific anticancer mechanisms and robust in vivo antitumor efficacy. | Bioorg Chem | 2026 | 42150409 | PubTator, text mining | PubMed |
| Discovery of Novel Alkynylbenzene Scaffold-Based PTPN2-Selective Degrader PD-305 with Exceptional Potency and In Vivo Efficacy. | J Med Chem | 2026 | 42132329 | PubTator, text mining | PubMed |
| HIT101308137 and HIT104293658 nominate dual target chemotypes for PTPN1 and PTPN2 with preliminary selectivity in colorectal cancer cells. | Front Chem | 2026 | 42079868 | PubTator, text mining | PubMed |
| An integrated microbiome-drug interaction and bioinformatics approach identifies active deglycosylated and glycosidic chain metabolites of Platycodin D targeting PTPN2/HIF1A in acute lung injury. | Biol Direct | 2026 | 41987241 | PubTator, text mining | PubMed |
| PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses. | EMBO Rep | 2026 | 41986797 | PubTator, text mining | PubMed |
| Novel Compounds as PTPN2 Inhibitors for Treating Cancer. | ACS Med Chem Lett | 2026 | 41982726 | PubTator, text mining | PubMed |
| Negative correlation between microRNA and insulin sensitivity gene expression in adipose tissue: potential implications for diabetes and neurodegenerative diseases. | Nutr Metab (Lond) | 2026 | 41975450 | PubTator, text mining | PubMed |
| An in vivo CRISPR screen unveils promising target genes to improve CAR-T cell efficacy in a solid tumor model. | Mol Ther | 2026 | 41935953 | PubTator, text mining | PubMed |
| Multi-omics identification of a programmed cell death-related signature and potential target P4HB for bladder cancer based on a 101-combination machine learning and experimental validation. | Clin Exp Med | 2026 | 41925913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5771/papers